NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
20 hedge funds and large institutions have $673K invested in InVivo Therapeutics Holdings Corp in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.
Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$27K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$9K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3K |
| 4 |
IA
4
IFP Advisors
Tampa,
Florida
|
$2K |
| 5 |
5
Citigroup
New York
|
$1K |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$101K |
| 2 |
VF
2
Virtu Financial
New York
|
$0 |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
HF
4
HRT Financial
New York
|
$0 |
| 5 |
TSS
5
Two Sigma Securities
New York
|
$0 |
